Catalyst Calendar

Tue, Sep 15, 2026

1 updates

4:36 PM

Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program

NEW YORK, NY, and WASHINGTON, DC, September 15, 2026 — Royalty Pharma and Blood Cancer United today announced a $7.5 million donation from Royalty Pharma to support Blood Cancer United’s Therapy Acceleration Program (TAP), a collaborative venture philanthropy initiative designed to accelerate the development of promising blood cancer therapies through...

royaltypharma.com

Wed, Sep 9, 2026

1 updates

RPRX

4:07 PM

Royalty Pharma to present at upcoming investor conferences

NEW YORK, NY, September 9, 2026 — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of September: Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 2:35 p.m....

royaltypharma.com

Fri, Sep 4, 2026

1 updates

RPRX

7:09 PM

Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen

NEW YORK, NY, September 4, 2026 — Royalty Pharma plc (Nasdaq: RPRX) today announced an update on Novartis’ Phase 3 results from the HORIZON outcomes trial for pelacarsen, an antisense oligonucleotide studied in patients with atherosclerotic cardiovascular (CV) disease and elevated lipoprotein(a), or Lp(a)....

Trial Results • Phase 3Phase 3 topline results Fri, Sep 4, 2026royaltypharma.com